CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 6
- PositionGross margin is 13.1%, lower than 95% of its Specialty Industrial Machinery peers (median 25.9%)
- FinancialsHigh earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
768.30BKRW554.56M · vs all stocks (USD)
Revenue (TTM)
93.45BKRW67.45M · vs all stocks (USD)
Profit Margin
0.42%vs Specialty Industrial Machinery peers
Beta
2.33xvs all stocks
52-Week Change
60.16%vs all stocks
Market Capitalization
768.30BKRW554.56M · vs all stocks (USD)
Enterprise Value
736.35BKRW531.50M · vs all stocks (USD)
Price to Sales (TTM)
8.22xvs Specialty Industrial Machinery peers
Price to Book (MRQ)
8.64xvs Specialty Industrial Machinery peers
Enterprise to Revenue
7.88xvs Specialty Industrial Machinery peers
Gross Margin
13.11%vs Specialty Industrial Machinery peers
Profit Margin
0.42%vs Specialty Industrial Machinery peers
Operating Margin
1.90%vs Specialty Industrial Machinery peers
Return on Assets (TTM)
-1.06%vs Specialty Industrial Machinery peers
Return on Equity (TTM)
0.44%vs Specialty Industrial Machinery peers
Revenue (TTM)
93.45BKRW67.45M · vs all stocks (USD)
Revenue per Share (TTM)
9.58KKRWUpdated Sep 19, 2026Quarterly Revenue Growth
34.20%vs Specialty Industrial Machinery peers
Gross Profit (TTM)
10.21BKRW7.37M · vs all stocks (USD)
EBITDA (TTM)
-725.43MKRW-523.62K · vs all stocks (USD)
Net Income (TTM)
390.46MKRW281.84K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
34.19%vs Specialty Industrial Machinery peers
Operating Cash Flow (TTM)
-1.69BKRW-1.22M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.84BKRW-2.77M · vs all stocks (USD)
Payout Ratio
0.00%vs Specialty Industrial Machinery peers
Revenue
75.74BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
68.81BKRWFY2025 · Dec 31, 2025Gross Profit
6.92BKRWFY2025 · Dec 31, 2025Operating Income
-5.66BKRW-4.09M · vs all stocks (USD)
Pre-tax Income
-4.99BKRWFY2025 · Dec 31, 2025Income Tax Expense
207.78MKRWFY2025 · Dec 31, 2025Net Income
-5.20BKRWFY2025 · Dec 31, 2025EBIT
-4.98BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-3.71BKRWFY2025 · Dec 31, 2025Research & Development
1.63BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
3.60BKRWFY2025 · Dec 31, 2025Other Operating Expenses
130.67MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
823.86MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
8.12MKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.20BKRWFY2025 · Dec 31, 2025Operating Cash Flow
-4.57BKRWFY2025 · Dec 31, 2025Free Cash Flow
-4.85BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
31.58BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.20BKRWFY2025 · Dec 31, 2025Other Non-cash Items
-839.72MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
3.56BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.08BKRWFY2025 · Dec 31, 2025Capital Expenditures
-280.38MKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-23.19MKRWFY2025 · Dec 31, 2025Other Investing Activity
-1.84MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-282.23MKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-6.02MKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
0.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-6.02MKRWFY2025 · Dec 31, 2025Shares Outstanding
9.75MSharesUpdated Sep 19, 2026Float Shares
6.49MSharesUpdated Sep 19, 2026% Held by Insiders
33.40%vs all stocks
% Held by Institutions
11.20%vs all stocks
Total Cash (MRQ)
31.16BKRW22.49M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.20KKRWUpdated Sep 19, 2026Total Debt (MRQ)
186.88MKRW134.89K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0021xvs Specialty Industrial Machinery peers
Current Ratio (MRQ)
3.16xvs Specialty Industrial Machinery peers
Book Value per Share (MRQ)
9.12KKRWUpdated Sep 19, 2026Total Assets
109.14BKRW78.78M · vs all stocks (USD)
Total Current Assets
76.33BKRWFY2025 · Dec 31, 2025Total Liabilities
22.33BKRWFY2025 · Dec 31, 2025Total Non-current Assets
32.81BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
290.87MKRWFY2025 · Dec 31, 2025Total Current Liabilities
22.04BKRWFY2025 · Dec 31, 2025Cash Equivalents
31.58BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
31.58BKRWFY2025 · Dec 31, 2025Accounts Receivable
21.58BKRWFY2025 · Dec 31, 2025Inventory
21.75BKRWFY2025 · Dec 31, 2025Accounts Payable
14.75BKRWFY2025 · Dec 31, 2025Short-term Debt
101.58MKRWFY2025 · Dec 31, 2025Other Current Liabilities
-480.00KRWFY2025 · Dec 31, 2025Long-term Debt
121.25MKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-400.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
4.88BKRWFY2025 · Dec 31, 2025Retained Earnings
23.13BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
86.81BKRW62.66M · vs all stocks (USD)
52-Week Low
42.05KKRWUpdated Sep 19, 202652-Week High
171.60KKRWUpdated Sep 19, 202652-Week Change
60.16%vs all stocks
Beta
2.33xvs all stocks
50-Day MA
73.13KKRWUpdated Sep 19, 2026200-Day MA
77.46KKRWUpdated Sep 19, 2026Avg 10-Day Volume
121.31KSharesUpdated Sep 19, 2026Avg 30-Day Volume
154.16KSharesUpdated Sep 19, 2026Diluted EPS (TTM)
-533.00KRWUpdated Sep 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 13.1%, lower than 95% of its Specialty Industrial Machinery peers (median 25.9%)Significant
Gross margin: 0.13Industry median: 0.26Industry P5: 0.13Peers compared: 361
Debt-to-equity is 0×, lower than 95% of its Specialty Industrial Machinery peers (median 0.17×)Notable
Debt-to-equity: 0.00Industry median: 0.17Industry P5: 0.00Peers compared: 361
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 281,835.76Operating Cash Flow (USD, TTM): -1,221,224.253
Financial Health
High earnings qualityNotable
Earnings Quality Score: 2.13
Supply Chain
Downstream position: depends on 12 industries, supplies 6Notable
Outgoing: 6.00Incoming: 12.00
High connectivity hub: 18 industry connectionsNotable
Total Connections: 18.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shenzhen Jasic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shanghai Everjoy Health Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Shenzhen Maxonic Automation Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Hyster-Yale Materials Handling, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Changchai Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Xinjiang Ba Yi Iron & Steel Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Gallant Precision Machining Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Zhejiang Yuejian Intelligent Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Australian Agricultural Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hangzhou Zhengqiang Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Abivax SA
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
ADC Therapeutics S.A.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ifishdeco Tbk PT
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated